Skip to main content

Svati Hasmukh Shah

Ursula Geller Distinguished Professor of Research in Cardiovascular Diseases
Medicine, Cardiology
Duke Box 104775, Durham, NC 27701
DUMC Box 3445, Durham, NC 27710

Current Duke Appointments & Affiliations


Ursula Geller Distinguished Professor of Research in Cardiovascular Diseases · 2023 - Present Medicine, Cardiology, Medicine
Professor of Medicine · 2019 - Present Medicine, Cardiology, Medicine
Associate Dean for Translational Research · 2024 - Present School of Medicine
Professor of Biostatistics and Bioinformatics · 2022 - Present Biostatistics & Bioinformatics, Division of Translational Biomedical, Biostatistics & Bioinformatics
Member in the Duke Clinical Research Institute · 2010 - Present Duke Clinical Research Institute, Institutes and Centers
Member of Duke Molecular Physiology Institute · 2013 - Present Duke Molecular Physiology Institute, Institutes and Centers

Recent News Items


Published July 6, 2026
Duke Heart Specialists Lead American Heart Association
Published September 25, 2023
Heartfelt Gratitude: Duke Patient Contributes to OneDukeGen Study
Published September 12, 2023
New Center for Precision Health Aims to Transform Population Health, Patient Care

View All News Items

Recent Scholarly Works


Serial assessment of NT-proBNP and high-sensitivity cardiac troponin with glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes: Insights from EXSCEL.

Journal article Am Heart J · September 2026 BACKGROUND: In the EXSCEL trial, exenatide did not reduce major adverse cardiovascular events (MACE), but heterogeneity of benefit and the role of cardiac biomarkers remain uncertain. We evaluated the prognostic value of baseline and 1-year changes in N-te ... Full text Link to item Cite

A validated, modifiable proteomic score from the EXSCEL trial predicts cardiovascular events in diabetes.

Journal article JCI Insight · August 24, 2026 BACKGROUNDAdults with type 2 diabetes mellitus (T2DM) are at increased risk for stroke, myocardial infarction, and cardiovascular death, yet individual risk is heterogeneous and incompletely captured by clinical models.METHODSIn the Exenatide Study of Card ... Full text Link to item Cite

HFpEF and MASLD: converging mechanisms and clinical implications.

Journal article Nat Rev Cardiol · August 2026 Heart failure with preserved ejection fraction (HFpEF) and metabolic dysfunction-associated steatotic liver disease (MASLD) are increasingly prevalent, interrelated conditions driven by the global rise in obesity and metabolic syndrome. Once viewed in isol ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


1/3 CTSA UM1 at Duke University

ResearchCore Co-Lead · Awarded by National Center for Advancing Translational Sciences · 2025 - 2032

Computational Biology and Bioinformatics Training Grant

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2026 - 2031

Integrated Training in Anesthesiology Research

Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 1996 - 2031

View All Grants

Education


University of Washington · 1998 M.D.
Johns Hopkins University · 1994 M.H.S.